THIS SITE IS INTENDED
FOR US CONSUMERS

  • BEVESPI AEROSPHERE is a prescription medication used long-term to treat adults with COPD READ MORE...(chronic obstructive pulmonary disease), including chronic bronchitis, emphysema, or both. SHOW LESS
  • BEVESPI AEROSPHERE is not a rescue inhaler and is not for use to treat sudden COPD symptoms. READ MORE...It is not for use in asthma. SHOW LESS

BEVESPI AEROSPHERE

AIMS TO OPEN AIRWAYS TO THE MAX

A maintenance treatment for adults with COPD.

BEVESPI AEROSPHERE is a combination of two COPD medicines. When used long-term—two puffs, twice a day—BEVESPI AEROSPHERE works two ways to help open airways and keep them open. Open airways can help open your world for better breathing.

It is not a rescue inhaler and is not used to treat sudden COPD symptoms. It is not for the treatment of asthma.

Starting June 1, 2024, eligible patients will pay as little as $35 per month for their BEVESPI.Δ

Click here to see if you are eligible and to learn more.

Savings_card

ΔTerms and conditions apply. Government restrictions exclude people enrolled in federal government insurance programs from co-pay support. Click here to see if you are eligible and to learn more.

openforbreathing_sign

HOW BEVESPI
AEROSPHERE CAN HELP

BEVESPI Inhaler

BEVESPI AEROSPHERE aims to open airways to the max. BEVESPI AEROSPHERE contains two medicines that work in different ways. When used long-term twice daily, BEVESPI AEROSPHERE helps to open airways and keep them open and can make it easier to breathe.

In two 24-week clinical trials, effects of BEVESPI AEROSPHERE on lung function for better breathing were shown to be greater than either of its individual medicines alone.* Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough.

*Individual results may vary.

BEVESPI AEROSPHERE is not a rescue inhaler and is not for use to treat sudden COPD symptoms. It is not for use in asthma.

How BEVESPI AEROSPHERE Works
BEVESPI Inhaler

TAKING BEVESPI
AEROSPHERE

Watch a video showing you how to use your inhaler.

Could I have COPD

Could I Have COPD?

Have you noticed any differences or difficulty in your breathing? Even if you generally “feel” okay, it might be worth talking to your doctor. Learn about COPD, its symptoms, what causes it, and how it can be diagnosed and treated.

Could I have COPD

STEP INSIDE YOUR
BREATHING ROOM

Resources & Support

Breathing Room is a dedicated place designed to help you simplify, streamline, and manage your breathing day-to-day.

Breathing Room COPD Resources

IMPORTANT SAFETY INFORMATION

  • BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased
  • BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma
  • Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms
  • Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE
  • Tell your healthcare provider about all the medicines you take and about all your health conditions
  • Do not use BEVESPI AEROSPHERE more often than prescribed
  • Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason
  • Call your healthcare provider or get medical care right away if:
    • Your breathing problems get worse
    • You need to use your rescue inhaler more often than usual or your rescue inhaler doesn’t work as well at relieving symptoms

BEVESPI AEROSPHERE can cause serious side effects, including:

  • Sudden breathing problems immediately after inhaling your medicine
  • Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems
  • Fast or irregular heartbeat, increased blood pressure, chest pain
  • Tremor or nervousness
  • New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose
  • New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away
  • High blood sugar or low blood potassium

Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away.

APPROVED USE

BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma.

Please read full Prescribing Information , including Patient Information and Instructions for Use .

IMPORTANT SAFETY INFORMATION

  • BEVESPI AEROSPHERE combines an anticholinergic, glycopyrrolate, and a long-acting beta2-adrenergic agonist (LABA) medicine, formoterol fumarate. LABA medicines, such as formoterol, when used alone can increase the risk of serious asthma-related events, including hospitalizations and death from asthma problems. When an inhaled corticosteroid (ICS) and LABA are used together, this risk is not significantly increased

You may report side effects related to AstraZeneca products.

USA flagThis site is intended for US Consumers only.

The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about BEVESPI AEROSPHERE or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if BEVESPI AEROSPHERE is right for you.

X


BEVESPI_AEROSPHERE